Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market
Holding CSTL?
Track your performance easily

Castle Biosciences (CSTL) Financial Statements

396 Followers

Castle Biosciences Financial Overview

Castle Biosciences's market cap is currently ―. The company's EPS TTM is $0.199; its P/E ratio is 168.98; Castle Biosciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 85.78M$ 87.00M$ 72.97M$ 66.12M$ 61.49M
Gross Profit$ 70.17M$ 72.48M$ 59.08M$ 53.70M$ 50.17M
EBIT$ 8.47M$ 8.10M$ -2.43M$ -2.54M$ -6.87M
EBITDA$ 12.02M$ 13.15M$ -787.00K$ 685.00K$ -3.70M
Net Income Common Stockholders$ 2.27M$ 8.92M$ -2.53M$ -2.58M$ -6.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 279.80M$ 259.70M$ 239.20M$ 243.10M$ 229.70M
Total Assets$ 514.57M$ 487.31M$ 458.51M$ 453.34M$ 436.02M
Total Debt$ 26.74M$ 25.19M$ 25.05M$ 15.31M$ 14.53M
Net Debt$ -253.06M$ -234.51M$ -214.15M$ -227.79M$ -215.17M
Total Liabilities$ 73.51M$ 63.42M$ 56.05M$ 62.07M$ 50.24M
Stockholders Equity$ 441.06M$ 423.88M$ 402.46M$ 391.27M$ 385.78M
Cash Flow-
Free Cash Flow$ 16.96M$ 18.77M$ -15.98M$ 14.79M$ 2.56M
Operating Cash Flow$ 23.34M$ 24.00M$ -6.83M$ 18.59M$ 5.01M
Investing Cash Flow$ -14.79M$ -21.42M$ -19.70M$ -7.67M$ -9.71M
Financing Cash Flow$ 838.00K$ 42.00K$ 10.64M$ -3.30M$ 45.00K
Currency in USD

Castle Biosciences Earnings and Revenue History

Castle Biosciences Debt to Assets

Castle Biosciences Cash Flow

Castle Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis